Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Mouth Neoplasms 1Laryngeal Neoplasms 1Esophageal Neoplasms 1Alcohol Drinking 1

Interventions

Cisplatin 9Cetuximab 6Radiotherapy, Intensity-Modulated 5Docetaxel 4Radiotherapy 3Fluorouracil 3Carboplatin 3pembrolizumab 2durvalumab 2Radiation 2Hydroxyurea 2Drug Therapy 2Celecoxib 2Bupropion 2130-nm albumin-bound paclitaxel 21,2-diaminocyclohexaneplatinum II citrate 2sodium thiosulfate 1gossypol acetic acid 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1Tobacco Use Cessation Devices 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Platinum 1Pilocarpine 1Oral Hygiene 1Nicotine Replacement Therapy 1Nicotine 1NVP-BKM120 1Immunoglobulin G 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Laryngeal Neoplasms × Alcoholic Beverages × Clear all
NCT06129487 2025-11-14

Evaluations of Alcohol Warning Labels

University of Connecticut

Phase NA Completed
1,053 enrolled 15 charts
GastrointestinalHead & Neck

Alcohol Drinking, Esophageal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡